Cargando…

Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments

For a new molecular entity (NME) to become a drug, it is not only essential to have the right biological activity also be safe and efficient, but it is also required to have a favorable pharmacokinetic profile including toxicity (ADMET). Consequently, there is a need to predict, during the early sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Dulsat, Júlia, López-Nieto, Blanca, Estrada-Tejedor, Roger, Borrell, José I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864198/
https://www.ncbi.nlm.nih.gov/pubmed/36677832
http://dx.doi.org/10.3390/molecules28020776
_version_ 1784875523548119040
author Dulsat, Júlia
López-Nieto, Blanca
Estrada-Tejedor, Roger
Borrell, José I.
author_facet Dulsat, Júlia
López-Nieto, Blanca
Estrada-Tejedor, Roger
Borrell, José I.
author_sort Dulsat, Júlia
collection PubMed
description For a new molecular entity (NME) to become a drug, it is not only essential to have the right biological activity also be safe and efficient, but it is also required to have a favorable pharmacokinetic profile including toxicity (ADMET). Consequently, there is a need to predict, during the early stages of development, the ADMET properties to increase the success rate of compounds reaching the lead optimization process. Since Lipinski’s rule of five, the prediction of pharmacokinetic parameters has evolved towards the current in silico tools based on empirical approaches or molecular modeling. The commercial specialized software for performing such predictions, which is usually costly, is, in many cases, not among the possibilities for research laboratories in academia or at small biotech companies. Nevertheless, in recent years, many free online tools have become available, allowing, more or less accurately, for the prediction of the most relevant pharmacokinetic parameters. This paper studies 18 free web servers capable of predicting ADMET properties and analyzed their advantages and disadvantages, their model-based calculations, and their degree of accuracy by considering the experimental data reported for a set of 24 FDA-approved tyrosine kinase inhibitors (TKIs) as a model of a research project.
format Online
Article
Text
id pubmed-9864198
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98641982023-01-22 Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments Dulsat, Júlia López-Nieto, Blanca Estrada-Tejedor, Roger Borrell, José I. Molecules Review For a new molecular entity (NME) to become a drug, it is not only essential to have the right biological activity also be safe and efficient, but it is also required to have a favorable pharmacokinetic profile including toxicity (ADMET). Consequently, there is a need to predict, during the early stages of development, the ADMET properties to increase the success rate of compounds reaching the lead optimization process. Since Lipinski’s rule of five, the prediction of pharmacokinetic parameters has evolved towards the current in silico tools based on empirical approaches or molecular modeling. The commercial specialized software for performing such predictions, which is usually costly, is, in many cases, not among the possibilities for research laboratories in academia or at small biotech companies. Nevertheless, in recent years, many free online tools have become available, allowing, more or less accurately, for the prediction of the most relevant pharmacokinetic parameters. This paper studies 18 free web servers capable of predicting ADMET properties and analyzed their advantages and disadvantages, their model-based calculations, and their degree of accuracy by considering the experimental data reported for a set of 24 FDA-approved tyrosine kinase inhibitors (TKIs) as a model of a research project. MDPI 2023-01-12 /pmc/articles/PMC9864198/ /pubmed/36677832 http://dx.doi.org/10.3390/molecules28020776 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Dulsat, Júlia
López-Nieto, Blanca
Estrada-Tejedor, Roger
Borrell, José I.
Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments
title Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments
title_full Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments
title_fullStr Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments
title_full_unstemmed Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments
title_short Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments
title_sort evaluation of free online admet tools for academic or small biotech environments
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864198/
https://www.ncbi.nlm.nih.gov/pubmed/36677832
http://dx.doi.org/10.3390/molecules28020776
work_keys_str_mv AT dulsatjulia evaluationoffreeonlineadmettoolsforacademicorsmallbiotechenvironments
AT lopeznietoblanca evaluationoffreeonlineadmettoolsforacademicorsmallbiotechenvironments
AT estradatejedorroger evaluationoffreeonlineadmettoolsforacademicorsmallbiotechenvironments
AT borrelljosei evaluationoffreeonlineadmettoolsforacademicorsmallbiotechenvironments